As an Amazon Associate, PauseAndFlourish earns from qualifying purchases.Product prices and availability are accurate as of the date reviewed.

PauseAndFlourishMenopause Wellness Reviews & Guidance

Clinical Trial

Romosozumab builds bone strength in postmenopausal women.

This clinical trial shows that romosozumab treatment significantly increases bone mass and strength, reducing fracture risk in postmenopausal women with osteoporosis. The positive effects on bone remodeling units are observed early in treatment and continue for at least 12 months.

Citation

Eriksen EF, Boyce RW, Shi Y, Brown JP, Betah D, Libanati C, Oates M, Chapurlat R, Chavassieux P. Reconstruction of remodeling units reveals positive effects after 2 and 12 months of romosozumab treatment. J Bone Miner Res. 2024 Jul 23;39(6):729-736. doi: 10.1093/jbmr/zjae055. PMID: 38640512 Clinical Trial.

View Source